Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?
作者信息
Kim Yeon-Ji, Chung Woo Chul
机构信息
Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
出版信息
Korean J Intern Med. 2020 May;35(3):544-546. doi: 10.3904/kjim.2020.139. Epub 2020 Apr 29.
Abstract
摘要
相似文献
1
Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?基于人群的胃癌筛查中血清胃蛋白酶原检测有必要吗？
Korean J Intern Med. 2020 May;35(3):544-546. doi: 10.3904/kjim.2020.139. Epub 2020 Apr 29.
2
The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.中国组织学胃炎分期-“OLGA/OLGIM”与血清胃蛋白酶原检测在评估胃萎缩/肠化生中的相关性
Scand J Gastroenterol. 2017 Aug;52(8):822-827. doi: 10.1080/00365521.2017.1315739. Epub 2017 Apr 22.
3
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.基于血清胃蛋白酶原和幽门螺杆菌抗体滴度评估的慢性活动性胃炎和由此导致的胃萎缩与癌症发展的关系。
Int J Cancer. 2014 Mar 15;134(6):1445-57. doi: 10.1002/ijc.28470. Epub 2013 Oct 3.
4
[Potentialities of a serological method in diagnosis of atrophic gastritis].[血清学方法在萎缩性胃炎诊断中的潜力]
Ter Arkh. 2008;80(2):15-21.
5
Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.广泛萎缩性胃炎患者血清总胃饥饿素水平降低：与组织学参考中的胃蛋白酶原比较
Scand J Gastroenterol. 2016;51(2):137-44. doi: 10.3109/00365521.2015.1083049.
6
[The variation and clinical significance of serum pepsinogen subgroups in atrophic gastritis and gastric cancer].
Zhonghua Nei Ke Za Zhi. 1986 Oct;25(10):608-10, 637-8.
7
Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group.血清胃蛋白酶原I在胃癌及发育异常早期内镜诊断中的意义。赫尔辛基胃炎研究小组。
Scand J Gastroenterol. 2000 Sep;35(9):950-6. doi: 10.1080/003655200750023011.
8
9
[Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].[胃癌高发区居民血清胃蛋白酶原水平与胃黏膜变化的相关性]
Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):507-11.
10
Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.贲门癌的两种不同病因；来自胃萎缩和幽门螺杆菌状态的病前血清学标志物的证据。
Gut. 2007 Jul;56(7):918-25. doi: 10.1136/gut.2006.114504. Epub 2007 Feb 22.
引用本文的文献
1
PG I and PG II show unique value in diagnosing postoperative biochemical recurrence in patients with gastric cancer after total gastrectomy.胃蛋白酶原I和胃蛋白酶原II在诊断胃癌全胃切除术后患者的术后生化复发方面具有独特价值。
Discov Oncol. 2024 Jun 17;15(1):231. doi: 10.1007/s12672-024-01091-0.
2
[Diagnostic Value of Serum Pepsinogen Ⅰ/Pepsinogen Ⅱ Combined with Tumor Markers for -Positive Early-Stage Gastric Cancer].血清胃蛋白酶原Ⅰ/胃蛋白酶原Ⅱ联合肿瘤标志物对早期阳性胃癌的诊断价值
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Jan;54(1):186-191. doi: 10.12182/20230160111.
3
Diagnostic performances of pepsinogens and gastrin-17 for atrophic gastritis and gastric cancer in Mongolian subjects.蒙古人群中胃蛋白酶原和胃泌素 17 对萎缩性胃炎和胃癌的诊断性能。
PLoS One. 2022 Oct 17;17(10):e0274938. doi: 10.1371/journal.pone.0274938. eCollection 2022.
4
Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening to Eradication in Korea.韩国胃癌预防从内镜筛查到根除的范式转变的当前证据。
J Gastric Cancer. 2022 Jul;22(3):169-183. doi: 10.5230/jgc.2022.22.e22.
5
Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer.血清胃蛋白酶原和糖类抗原72-4（CA72-4）联合胃泌素-17（G-17）检测在早期胃癌筛查、诊断及评估中的应用
J Gastrointest Oncol. 2021 Jun;12(3):1042-1048. doi: 10.21037/jgo-21-254.
本文引用的文献
1
Diagnostic performance of serum pepsinogen assay for the prediction of atrophic gastritis and gastric neoplasms: Protocol for a systematic review and meta-analysis.血清胃蛋白酶原检测对萎缩性胃炎和胃肿瘤预测的诊断性能：系统评价与荟萃分析方案
Medicine (Baltimore). 2019 Jan;98(4):e14240. doi: 10.1097/MD.0000000000014240.
2
Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm.血清胃蛋白酶原水平与胃肿瘤性胃萎缩的临床相关性。
Korean J Intern Med. 2020 Apr;35(3):550-558. doi: 10.3904/kjim.2018.282. Epub 2018 Nov 7.
3
A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication.胃蛋白酶原I/II比值显著升高是幽门螺杆菌成功根除的可靠生物标志物。
PLoS One. 2017 Aug 30;12(8):e0183980. doi: 10.1371/journal.pone.0183980. eCollection 2017.
4
Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays.通过循环胃蛋白酶原检测胃萎缩：三种检测方法的比较
Helicobacter. 2017 Aug;22(4). doi: 10.1111/hel.12393. Epub 2017 May 29.
5
Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality.韩国国家癌症筛查计划在降低胃癌死亡率方面的效果。
Gastroenterology. 2017 May;152(6):1319-1328.e7. doi: 10.1053/j.gastro.2017.01.029. Epub 2017 Jan 29.
6
Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer.萎缩性胃炎及肠化生作为胃癌癌前病变的综述。
J Cancer Prev. 2015 Mar;20(1):25-40. doi: 10.15430/JCP.2015.20.1.25.
7
Screening for gastric cancer: the usefulness of endoscopy.胃癌筛查：内镜检查的效用
Clin Endosc. 2014 Nov;47(6):490-6. doi: 10.5946/ce.2014.47.6.490. Epub 2014 Nov 30.
8
The role of serum pepsinogen in the detection of gastric cancer.血清胃蛋白酶原在胃癌检测中的作用。
Gut Liver. 2010 Sep;4(3):307-19. doi: 10.5009/gnl.2010.4.3.307. Epub 2010 Sep 24.
9
Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer.胃癌患者血浆及肿瘤组织中胃饥饿素浓度的临床意义
J Surg Res. 2007 Dec;143(2):344-9. doi: 10.1016/j.jss.2007.02.017. Epub 2007 Aug 3.
10
Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.结合幽门螺杆菌抗体和血清胃蛋白酶原状态预测胃癌的发生：一项前瞻性内镜队列研究。
Gut. 2005 Jun;54(6):764-8. doi: 10.1136/gut.2004.055400.
Zotero 插件